Skip to content
Fast MDx logo
  • About
  • NGX 124 Platform
  • Partners
  • News/Press
  • Contact
  • BOOK TRIAL

News/Press

Latest News

  • Pertussis – Whooping Cough, the “100 Day Cough”

    READ MORE...

  • Acute Respiratory Infection Rates

    READ MORE...

  • Fast MDx Ltd. achieves ISO 13485:2016 Quality System Certification

    READ MORE...

  • Pandemic preparedness with the mobile Fast MDx platform

    READ MORE...

  • A step forward in the diagnosing of Long COVID

    READ MORE...

  • This summer, Covid-19 safety is more individualised than ever

    READ MORE...

  • Jason Leitch concerned about winter amid Covid upswing

    READ MORE...

  • Circulating Tumour DNA Valuable for Prognosis & Management

    READ MORE...

Previous123Next

In the Press/Press Releases

No PR articles found, sorry.

Read the latest information from Fast MDx on LinkedIn.

Fast MDx - Automated Near-Patient MDx Testing
  • +44(0)203 021 3750

  • rlewis@fastmdx.com
  • LinkedIn

  • 65 Bideford Ave
    Perivale
    Greenford
    UB6 7PP
    United Kingdom
  • About Fast MDx

  • The NGX 124 platform

  • Development Partners

  • News/Press

  • Contact Us

Reserve your complimentary
one-week free trial in your lab
Book Trial

Company Details | Privacy Policy, Cookies & Diversity | Terms and Conditions | Sitemap

© Copyright 2019 – 2026 Fast MDx Limited

ISO-13485 certifiedCertified Social EnterprisePeople and Planet FirstBIVDA memberUKCA labelledEU-IVDR labelled

Page load link

FastMDx®

Discover Tomorrow’s Diagnostics Today with the NGX 124

The first completely open, low‑cost MDx platform that combines automated liquid handling with ultra‑fast qPCR to deliver extraordinary performance.

Don’t miss out, reserve your complimentary one‑week trial now to see firsthand how:

  • Effortlessly the NGX 124 runs
  • How it will elevate your lab’s efficiency and reduce your operating costs
  • Gives you a decisive competitive edge
  • Helps retain your biomedical scientists by allowing them to run more interesting testing

Find out more…

FastMDx®

NGX 124

The first completely open, low‑cost MDx platform that combines automated liquid handling with ultra‑fast qPCR to deliver extraordinary performance.

Don’t miss out, reserve your complimentary one‑week trial now to see firsthand how:

  • Effortlessly the NGX 124 runs
  • How it will elevate your lab’s efficiency and reduce your operating costs
  • Gives you a decisive competitive edge
  • Helps retain your biomedical scientists by allowing them to run more interesting testing

Find out more…
This website uses cookies and third party services. Read our privacy and cookie policy.
Ok
Go to Top